Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001445507 | SCV001648539 | likely benign | Dyskeratosis congenita, autosomal recessive 5; Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 | 2024-11-24 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001820138 | SCV002065265 | likely benign | not specified | 2021-05-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002456749 | SCV002736317 | likely benign | Inborn genetic diseases | 2022-05-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001826266 | SCV002095350 | likely benign | Dyskeratosis congenita | 2021-06-07 | no assertion criteria provided | clinical testing |